10.1046/j.1460-9568.2000.00260.x [DOI] [PubMed] [Google Scholar] Lamballe F., Genestine M., Caruso N., Arce V., Richelme S., Helmbacher F., et al
Ma XH, Liu JH, Liu CY, Sun WY, Duan WJ, Wang G, et al
Technology Appraisal TA875
As there were no specifically suitable positive control drugs for protective roles in PE, we chose the ferroptosis inhibitor Fer-1 as our option
Guan Y, Wang SR, Huang XZ, Xie QH, Xu YY, Shang D, Hao CM (2017) Nicotinamide mononucleotide, an NAD+ precursor, rescues age-associated susceptibility to AKI in a sirtuin 1dependent manner
However, thorough investigation and clinical trials are crucial to fully understand its potential and ensure its safe and effective use